Apremilast Versus Placebo for Genital Erosive Lichen Planus in Women: A Randomized Controlled Trial
{{output}}
Objectives: We set out to evaluate the efficacy and safety of phosphodiesterase-4 inhibitor apremilast for moderate-to-severe genital erosive lichen planus (GELP) in women. ... ...
